The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Stephenson Harwood

Living Wage
1 FINSBURY CIRCUS, LONDON, EC2M 7SH, ENGLAND
Tel:
Work 020 7329 4422
Fax:
Fax 020 7329 7100
DX:
64 LONDON CHANCERY LANE WC2
Email:
Web:
www.shlegal.com
Beijing, Dubai, Hong Kong, London, Paris, Piraeus and 4 more

Rob Jacob

Tel:
Work 020 7809 2072
Email:
Web:
www.shlegal.com
Stephenson Harwood

Work Department

Commercial litigation

Position

Rob is a partner specialising in both contentious and non-contentious IP issues with a particular focus on trade mark and copyright matters. He has particular expertise in the life sciences, offshore construction and luxury brands sectors.

Rob has a masters degree in Chemistry from Imperial College, London and a post-graduate diploma in IP law and practice. He trained and qualified into the IP team at Clifford Chance before joining Stephenson Harwood in 2009 specialising in all intellectual property matters.

Rob acted on DataCard Corporation v Eagle Technologies Limited ([2011] EWHC 244 (Pat)) where the firm successfully argued for the extension of trade mark law in relation to post-sale confusion. His other more recently reported cases include: Glaxo Wellcome UK Limited v Sandoz Ltd [2017] EWHC 3196 (Ch), Parainen Pearl Shipping Ltd v Kristian Gerhard Skipsrederi AS [2018] EWHC 2628 (Pat), Smart Reamer Drilling Systems v NOV Downhole Eurasia [2018] 1265 (IPEC) and Pathway IP Sarl v easyGroup Ltd [2018] EWHC 3608 (Ch). He has also successfully argued that residual goodwill subsists in the NICHOLSON gin brand (UK Decision: Opp 0520-14) and has successfully convinced OHIM's Board of Appeal that the shape of GSK's DISKUS inhaler was distinctive (R2074/2013-2).

On the non-contentious side, Rob's highlights include working on the public takeover of Biocompatibles plc by BTG plc, the US$3.8 billion sale of Piramal Enterprises' domestic formulations division to US pharmaceuticals giant Abbott, the acquisition of the worldwide rights to Florbetaben (a pioneering molecular imaging product for the diagnosis of early Alzheimer's disease) from Bayer Pharma AG and the US$220 million acquisition of EKOS corporation.

Rob is a recommended lawyer in the Legal 500 UK directory for intellectual property and pharmaceuticals and biotechnology with "notable strengths in trade mark work". Rob has been described as “a very brainy guy who thinks deeply about his cases. He is always stress-testing and playing devil’s advocate to be as well prepared as possible. He is unflappable and his measured manner is very reassuring.” (WTR 1000, 2019) Rob also wrote the intellectual property chapter of the book Offshore Construction Law and Practice published by Informa Law from Routledge.





London: TMT (technology, media and telecoms)

Intellectual property

Within: Intellectual property

The 'very reliable' practice at Stephenson Harwood has 'excellent legal skills and sharp commercial awareness' and 'excels at coordinating multi-jurisdictional litigation'. With 'excellent strength and depth in life sciences and pharmaceuticals work', the team attracts praise for being 'unique in its ability to switch its approach from big pharma to small biotech'; other strong sectors for the group include the retail, luxury brands, oil, gas and shipping industries. 'Stand-out litigator' and 'formidable negotiator' Eifion Morris is 'absolutely brilliant strategically' and leads the practice alongside the 'technically and legally superb' Alexandra Pygall. Rob Jacob has 'exceptional practical experience coupled with a commercial approach' and handles a combination of contentious and non-contentious matters for life science and energy sector clients, while recently promoted partner Naomi Leach focuses on transactional matters in the life sciences sector.

[back to top]

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Stephenson Harwood serves a range of pharma, biotech and healthcare clients, including startups, with a comprehensive range of expertise. This includes corporate and commercial; Andrew Edge has advised a number of major players in the sector on mergers, acquisitions and IPOs and Anthony Clare also advises on commercial and funding mandates.  Alexandra Pygall 'provides the highest quality advice' to her clients on all aspects of IP commercialisation including licensing and collaboration deals and routinely assists on the IP aspects of M&A. 'Excellent advisor' Rob Jacob also specialises in all aspects of IP advisory and contentious cases.

[back to top]


Back to index

Legal Developments by:
Stephenson Harwood

  • Companies should plan now to minimise their pension protection levy

    The amount that pension schemes have to pay to the Pension Protection Fund (PPF) for the year 2006/07 may have increased by as much as five times the previous year's levy. Employers who ultimately bear the cost of many pension schemes will need to make plans now to ensure the levy payable for the year 2008/09 is kept to a minimum.
    - Stephenson Harwood

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to